首页|清眩降压汤联合阿利沙坦酯片治疗原发性高血压病伴高脂血症临床研究

清眩降压汤联合阿利沙坦酯片治疗原发性高血压病伴高脂血症临床研究

扫码查看
目的:观察清眩降压汤联合阿利沙坦酯片治疗对原发性高血压病伴高脂血症患者血压、脂代谢及血栓相关因子水平的影响。方法:将96例原发性高血压病伴高脂血症患者按随机数字表分为对照组和观察组各48例。对照组患者予瑞舒伐他汀片和阿利沙坦酯片口服治疗,观察组患者在对照组治疗的基础上联合清眩降压汤治疗,两组疗程均为2周。观察两组患者治疗前后血压(白天平均血压、夜间平均血压、24h平均血压)、脂代谢相关指标[总胆固醇(TC)、甘油三酯(TG)、高密度脂蛋白胆固醇(HDL-C)、低密度脂蛋白胆固醇(LDL-C)]、血栓相关因子[血管细胞黏附分子(VCAM-1)、细胞间黏附分子-1(ICAM-1)、环氧化酶-1(COX-1)、组织型纤溶酶原激活因子(tPA)]水平的变化,比较两组的临床疗效和中医证候疗效。结果:治疗后观察组临床总有效率、中医证候总有效率高于对照组(均P<0。05);两组患者各时间段的平均血压及TC、TG、LDL-C、VCAM-1、ICAM-1水平均较治疗前显著降低,且观察组低于对照组(P<0。05);两组患者HDL-C水平、tPA水平较治疗前显著升高,且观察组高于对照组(P<0。05);对照组患者COX-1水平与治疗前比较无显著变化(P>0。05),而观察组患者COX-1水平较治疗前显著降低(P<0。05)。结论:清眩降压汤联合阿利沙坦酯片治疗原发性高血压病伴高脂血症疗效显著,可有效调控血压及脂代谢,进而减少血栓发生风险,值得临床推广应用。
Clinical study on Qinxuan Jiangya decoction combined with Allisartan Isoproxil tablets in the treatment of essential hypertension with hyperlipidemia
Objective:To observe the effect of Qingxuan Jiangya decoction combined with Allisartan Isoproxil tab-lets on blood pressure,lipid metabolism and thrombosis related factors in patients with essential hypertension and hy-perlipidemia.Methods:A total of 96 patients with essential hypertension complicated with hyperlipidemia were divid-ed into the control group and the observation group randomly,with 48 cases in each group.The patients in the control group were treated with Rosuvastatin tablets and Allisartan Isoproxil tablets,and the patients in the observation group were treated with Qingxuan Jiangya decoction on the basis of the control group.The treatment course was 2 weeks.The changes of blood pressure(daytime mean blood pressure,nighttime mean blood pressure,24 h mean blood pressure),lipid metabolism relates indicators[total cholesterol(TC),triglyceride(TG),high density lipoprotein cholesterol(HDL-C),low density lipoprotein cholesterol(LDL-C)],thrombus related factors[vascular cell adhesion molecule(VCAM-1),intercellular adhesion molecule-1(ICAM-1),cyclooxygenase-1(COX-1),tissue plasminogen activator(tPA)]were ob-served before and after treatment in the two groups.The clinical efficacy and TCM syndrome efficacy of the two groups were compared.Results:After treatment,the total effective rate and TCM syndrome efficacy of the observation group were higher than those of the control group(P<0.05).The average blood pressure and the levels of TC,TG,LDL-C,VCAM-1 and ICAM-1 in the two groups were significantly lower than those before treatment,and the observation group was lower than the control group(P<0.05).The levels of HDL-C and tPA in the two groups were significantly higher than those before treatment,and those in the observation group were higher than the control group(P<0.05).The level of COX-1 in the control group was not significantly changed compared with that before treatment(P>0.05),while the level of COX-1 in the observation group was significantly lower than that before treatment(P<0.05).Conclusion:Qingxuan Jiangya decoction combined with Allisartan Isoproxil tablets is effective in the treatment of primary hyperten-sion with hyperlipidemia.It can effectively regulate blood pressure and lipid metabolism,thereby reducing the risk of thrombosis,which is worthy of clinical application.

Qingxuan Jiangya decoctionAllisartan IsoproxilEssential hypertensionHyperlipidemiaThrombo-sisIntegrative therapy of Chinese and western medicine

陈杭、孙艳雷

展开 >

南京市中医院,江苏 南京 210006

清眩降压汤 阿利沙坦酯 原发性高血压 高脂血症 血栓 中西医结合疗法

2024

广西中医药
广西中医学院 中国中医药学会广西分会

广西中医药

影响因子:0.611
ISSN:1003-0719
年,卷(期):2024.47(2)
  • 18